Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repositori Institucional UIB
Publicación Artículo científico (JournalArticle)

Implementation of a digital tool for monitoring and managing the emotional and cognitive sequelae of post-intensive care syndrome: ICURA study protocol for a randomised clinical trial

  • Roca, Miquel
  • Fernández-Gonzalo, Sol
  • Llabrés-Álvarez, Esther
  • Riera-Sagrera, Maria
  • Llompart-Casasnovas, Aina
  • Salvá, Pilar
  • Castro, Adoración
  • Godoy-González, Marta
  • Doña-López, Elisabet
  • López-Aguilar, Josefina
  • Jodar, Mercè
  • Navarra-Ventura, Guillem
  • Gili, Margalida
[eng] Introduction: Intensive care units (ICUs) can be a particularly challenging environment for patients who are mentally vulnerable. In addition to the physical stress associated with critical illness and its management, there are physiological and psychosocial factors that can negatively impact a patient's mental health. Approximately half of ICU survivors will experience post-intensive care syndrome, a set of emotional, neuropsychological and physical sequelae that can significantly affect patients' functionality and quality of life, both in the short and long term. The main objective of this study is to investigate whether the ICU Recovery Answers (ICURA) digital follow-up platform can effectively detect emotional and cognitive problems in critically ill patients and its impact on functionality and health-related quality of life during the first year after ICU discharge. Methods and analysis: Multicentre longitudinal prospective study involving ICU adult patients, with randomised follow-up comparing a telemedicine monitoring programme versus usual medical care during 1 year after discharge. A total of 360 participants will be recruited during their ICU admission in two hospitals in Spain. Efficacy outcomes will focus on participants' level of functioning, assessed with the WHO Short Disability Assessment Schedule, and quality of life, measured with the 12-Item Short Form Survey at 1, 6 and 12 months after ICU discharge. Emotional state and cognitive impairment will be evaluated using the Patient Health Questionnaire-9, Generalised Anxiety Disorder-7 and Treatment-Outcome Post-Traumatic Stress Disorder Scale and the Montreal Cognitive Assessment by telephone at 1, 3, 6, 9 and 12 months after ICU discharge.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Occurrence, co-occurrence and persistence of symptoms of depression and post-traumatic stress disorder in survivors of COVID-19 critical illness Aparición, coexistencia y persistencia de síntomas de depresión y trastorno de estrés postraumático en supervivientes de enfermedad crítica por COVID-19

  • Navarra-Ventura, Guillem|||0000-0001-9839-7357
  • Godoy-González, Marta|||0000-0002-1374-918X
  • Gomà, Gemma|||0000-0002-1890-4855
  • Jódar Vicente, Mercè|||0000-0002-8913-5977
  • Sarlabous, Leonardo|||0000-0002-0495-8422
  • Santos-Pulpon, Verónica|||0000-0003-2685-9377
  • Xifra-Porxas, Alba|||0000-0002-9023-2432
  • Haro López, Candelaria de|||0000-0002-2668-1030
  • Roca Gas, Oriol|||0000-0003-3841-4551
  • Blanch, Lluís|||0000-0002-4158-7464
  • López-Aguilar, Josefina|||0000-0003-2359-3980
  • Fernández-Gonzalo, Sol|||0000-0003-0267-0617
Background: Intensive care unit (ICU) admission and invasive mechanical ventilation (IMV) are associated with psychological distress and trauma. The COVID-19 pandemic brought with it a series of additional long-lasting stressful and traumatic experiences. However, little is known about comorbid depression and post-traumatic stress disorder (PTSD). Objective: To examine the occurrence, co-occurrence, and persistence of clinically significant symptoms of depression and PTSD, and their predictive factors, in COVID-19 critical illness survivors. Method: Single-centre prospective observational study in adult survivors of COVID-19 with ≥24 h of ICU admission. Patients were assessed one and 12 months after ICU discharge using the depression subscale of the Hospital Anxiety and Depression Scale and the Davidson Trauma Scale. Differences in isolated and comorbid symptoms of depression and PTSD between patients with and without IMV and predictors of the occurrence and persistence of symptoms of these mental disorders were analysed. Results: Eighty-nine patients (42 with IMV) completed the 1-month follow-up and 71 (34 with IMV) completed the 12-month follow-up. One month after discharge, 29.2% of patients had symptoms of depression and 36% had symptoms of PTSD; after one year, the respective figures were 32.4% and 31%. Coexistence of depressive and PTSD symptoms accounted for approximately half of all symptomatic cases. Isolated PTSD symptoms were more frequent in patients with IMV (p≤.014). The need for IMV was associated with the occurrence at one month (OR = 6.098, p =.005) and persistence at 12 months (OR = 3.271, p =.030) of symptoms of either of these two mental disorders. Conclusions: Comorbid depressive and PTSD symptoms were highly frequent in our cohort of COVID-19 critical illness survivors. The need for IMV predicted short-term occurrence and long-term persistence of symptoms of these mental disorders, especially PTSD symptoms. The specific role of dyspnea in the association between IMV and post-ICU mental disorders deserves further investigation. Trial registration: ClinicalTrials.gov identifier: NCT04422444.